A mutational approach will be used to understand how the energy form ATP binding and hydrolysis is converted into myosin's force And motion generating capabilities.
One aim i s to understand how the two heads of myosin influence each other's function. Molecular biological technique will be used to engineer physiologically relevant """"""""asymmetric"""""""" heavy meromyosin constructs in which the two heads of the molecule differ in the state of light chain phosphorylation, in cycling rates, or in actin binding properties. The constructs will be analyzed by biochemical, kinetic (steady-state and transient), and mechanical (velocity and force at the population and single molecule level) techniques. These studies will test existing models for how the two heads interact as well as provide new insight into the positive or negative consequences of having non- identical heads.
A second aim i s to understand how the actomyosin interface changes as the weak to strong binding transition occurs. The functional impact of mutations at the interface will be analyzed by techniques described above. Image reconstruction of actin decorated withy S1 mutants, in conjunction with docking of the crystal structure, will be used to provide high resolution structural information regarding the actomyosin interface.
The third aim i s to crystallize a mutant that is arrested in the M.ATP* state to determine if ATP binding or ATP hydrolysis causes the conformational change that results in priming of the lever arm. The overall goal is to understand how the structural domains of myosin contribute to chemomechanical coupling.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Program Projects (P01)
Project #
1P01AR047906-01
Application #
6508666
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2001-09-21
Project End
2006-05-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Lowey, Susan; Saraswat, Lakshmi D; Liu, HongJun et al. (2007) Evidence for an interaction between the SH3 domain and the N-terminal extension of the essential light chain in class II myosins. J Mol Biol 371:902-13
Volkmann, Niels; Lui, Hongjun; Hazelwood, Larnele et al. (2007) The R403Q myosin mutation implicated in familial hypertrophic cardiomyopathy causes disorder at the actomyosin interface. PLoS One 2:e1123
Kad, Neil M; Patlak, Joseph B; Fagnant, Patricia M et al. (2007) Mutation of a conserved glycine in the SH1-SH2 helix affects the load-dependent kinetics of myosin. Biophys J 92:1623-31
Ali, M Yusuf; Krementsova, Elena B; Kennedy, Guy G et al. (2007) Myosin Va maneuvers through actin intersections and diffuses along microtubules. Proc Natl Acad Sci U S A 104:4332-6
Rovner, Arthur S; Fagnant, Patricia M; Trybus, Kathleen M (2006) Phosphorylation of a single head of smooth muscle myosin activates the whole molecule. Biochemistry 45:5280-9
Krementsova, Elena B; Hodges, Alex R; Lu, Hailong et al. (2006) Processivity of chimeric class V myosins. J Biol Chem 281:6079-86
Debold, Edward P; Patlak, Joseph B; Warshaw, David M (2005) Slip sliding away: load-dependence of velocity generated by skeletal muscle myosin molecules in the laser trap. Biophys J 89:L34-6
Volkmann, Niels; Liu, HongJun; Hazelwood, Larnele et al. (2005) The structural basis of myosin V processive movement as revealed by electron cryomicroscopy. Mol Cell 19:595-605
Warshaw, David M; Kennedy, Guy G; Work, Steven S et al. (2005) Differential labeling of myosin V heads with quantum dots allows direct visualization of hand-over-hand processivity. Biophys J 88:L30-2
Sherwood, Jennifer J; Waller, Guillermina S; Warshaw, David M et al. (2004) A point mutation in the regulatory light chain reduces the step size of skeletal muscle myosin. Proc Natl Acad Sci U S A 101:10973-8

Showing the most recent 10 out of 22 publications